The latest international news, analysis and features on the HIV epidemic from Avert. Share your views and expertise with your peers in the comments box below the articles.
On International Youth Day (12 August), we look at the importance of youth involvement and safe spaces to respond to the HIV challenge related to the youth bulge.
HIV prevention is in need of a re-boot, cried many at AIDS 2018. Where better to start than with the condom, the most simple and effective intervention in our toolkit.
Dolutegravir’s first bump in the road to global roll-out begs larger questions around women’s rights and access to contraceptives at the International AIDS Conference (AIDS 2018).
Condom use among adolescents is likely to increase over time following sexual health education, while other positive behaviours and attitudes towards sexual activity and risk are likely to wane, a wide-ranging evidence review suggests.
Despite the huge human and economic toll, research into hepatitis B remains drastically underfunded, and was recently alikened to a neglected tropical disease. But hope for a cure is growing.
Long-term survivors – those diagnosed before effective treatment for HIV was around – face unique challenges relating to their mental and physical health.
A new agenda to advance sexual and reproductive health and rights (SRHR) presented by the Guttmacher–Lancet Commission has wide-ranging implications for the HIV response
Progress on decriminalising same sex relations continues but it’s slow – and in the meantime stigma and discrimination continue to undermine the HIV response.
Self-testers are able to perform HIV tests and interpret the results as accurately as healthcare workers, a new evidence review has found.
Reassurance for women living with HIV as commonly prescribed HIV drug deemed as safe as other regimes.
New research highlights significant gaps in health outcomes for adolescents born with HIV across the world – but paints a hopeful picture for the future as treatment access expands.
Interim clinical trial results offer hope to people living with hepatitis C who stand to benefit from reduced price treatment, including the 2.3 million people who have HIV co-infection.